# Hematoma Block for Reduction of Distal Radius Fractures

> **NCT02129270** · PHASE4 · COMPLETED · sponsor: **HaEmek Medical Center, Israel** · enrollment: 24 (actual)

## Conditions studied

- Fractures of the Distal Radius

## Interventions

- **DRUG:** Lidocaine HCl 2% .
- **DRUG:** Lidocaine HCl 1%

## Key facts

- **NCT ID:** NCT02129270
- **Lead sponsor:** HaEmek Medical Center, Israel
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2015-02
- **Final completion:** 2018-08
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2020-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02129270

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02129270, "Hematoma Block for Reduction of Distal Radius Fractures". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02129270. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*